JINPAXO Trademark

Trademark Overview

On Friday, June 30, 2017, a trademark application was filed for JINPAXO with the United States Patent and Trademark Office. The USPTO has given the JINPAXO trademark a serial number of 87512908. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 17, 2020. This trademark is owned by AbbVie Biotechnology Ltd.. The JINPAXO trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
jinpaxo

General Information

Serial Number87512908
Word MarkJINPAXO
Filing DateFriday, June 30, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 17, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 21, 2017

Trademark Statements

Goods and Servicespharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, July 10, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAbbVie Biotechnology Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressHamilton HM11
BM
Party NameAbbVie Biotechnology Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressHamilton HM11
BM

Trademark Events

Event DateEvent Description
Monday, August 17, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, August 17, 2020ABANDONMENT - NO USE STATEMENT FILED
Wednesday, January 15, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 13, 2020EXTENSION 4 GRANTED
Monday, January 13, 2020EXTENSION 4 FILED
Monday, January 13, 2020TEAS EXTENSION RECEIVED
Thursday, July 4, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 2, 2019EXTENSION 3 GRANTED
Tuesday, July 2, 2019EXTENSION 3 FILED
Tuesday, July 2, 2019TEAS EXTENSION RECEIVED
Saturday, January 12, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 10, 2019EXTENSION 2 GRANTED
Thursday, January 10, 2019EXTENSION 2 FILED
Thursday, January 10, 2019TEAS EXTENSION RECEIVED
Tuesday, July 3, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 29, 2018EXTENSION 1 GRANTED
Friday, June 29, 2018EXTENSION 1 FILED
Friday, June 29, 2018TEAS EXTENSION RECEIVED
Tuesday, January 16, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 21, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 21, 2017PUBLISHED FOR OPPOSITION
Wednesday, November 1, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, October 13, 2017LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, October 12, 2017ASSIGNED TO LIE
Wednesday, September 27, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 27, 2017EXAMINER'S AMENDMENT ENTERED
Wednesday, September 27, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, September 27, 2017EXAMINERS AMENDMENT E-MAILED
Wednesday, September 27, 2017EXAMINERS AMENDMENT -WRITTEN
Wednesday, September 27, 2017ASSIGNED TO EXAMINER
Monday, July 10, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, July 4, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

jinpaxo gastrointestinal hormonal neurological respiratory ophthalmic dermatological psychiatric diseases disorders related